Search clinical trials for: Placebo (Part 2)
Total 68504 results
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
Merck Sharp & Dohme LLCTerminated
-
ImmunityBio, Inc.RecruitingQUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid TumorsMetastatic Solid TumorUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.RecruitingCML, Chronic Phase | CML, Accelerated PhaseChina
-
Janssen Research & Development, LLCCompletedTumor or LymphomaUnited States, France, Spain
-
Verona Pharma plcIqvia Pty LtdCompleted
-
U.S. Army Medical Research and Development CommandNational Institutes of Health (NIH); Mahidol UniversityCompletedDiarrhea | Dysentery | ShigellaThailand
-
Kadmon Corporation, LLCQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
Verrica Pharmaceuticals Inc.Instat Clinical Research; HeartcoR Solutions; Myonex; Vial Health Technology, IncRecruitingCarcinoma | Skin Cancer | Basal Cell Carcinoma | Cancer of the Skin, Basal Cell | Cancer of the SkinUnited States
-
M.D. Anderson Cancer CenterWithdrawnSTI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL AmyloidosisAcute Myeloid Leukemia (AML) | Refractory T Acute Lymphoblastic LeukemiaUnited States
-
Mereo BioPharmaNovartisTerminatedAcute Kidney InjuryTaiwan, United States, Israel
-
AceLink Therapeutics, Inc.Novotech (Australia) Pty LimitedCompletedAutosomal Dominant Polycystic KidneyAustralia
-
University of MinnesotaNational Institutes of Health (NIH)CompletedSmoking Abstinence | HRT | Non-HRT | Continued Smoking
-
OliPass CorporationCompleted
-
Beijing Biostar Pharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Verona Pharma plcIqvia Pty LtdCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Janssen Research & Development, LLCCompletedNeoplasms | Lymphoma | Adenocarcinoma | Esophagogastric JunctionJapan
-
Janssen Research & Development, LLCTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Leukemia, Lymphocytic, Chronic, B-CellUnited States, France, Spain, Belgium, Israel
-
Hoffmann-La RocheCompleted
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSmall Cell Lung CancerChina
-
Ferring PharmaceuticalsRecruitingInflammatory Gastrointestinal DiseasesGermany
-
MBX BiosciencesCompleted
-
Vertex Pharmaceuticals IncorporatedTerminatedEpilepsyUnited States, Germany
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedSystemic Exposure to Sunscreen IngredientsUnited States
-
AstraZenecaRecruitingLiver CirrhosisDenmark, Spain, Germany, United States, France, Australia, China, Netherlands, Belgium, Switzerland, Austria, United Kingdom, Taiwan, Canada, Czechia
-
Organon and CoCompleted
-
Jiangsu Rec-Biotechnology Co., Ltd.Completed
-
MedImmune LLCCompletedCardiovascular Disease | AtherosclerosisUnited States
-
Boehringer IngelheimTerminatedHealthy VolunteersNetherlands
-
AstraZenecaCompletedHealthy Volunteers | Tolerability | SafetyUnited Kingdom
-
Novartis PharmaceuticalsCompletedHematological MalignanciesGermany, Switzerland, France
-
Xuanzhu Biopharmaceutical Co., Ltd.RecruitingNonalcoholic Steatohepatitis (NASH)China
-
Czech Lymphoma Study GroupHoffmann-La Roche; Ministry of Health, Czech RepublicCompletedDiffuse Large B-Cell Lymphoma. | Primary Mediastinal B-Cell Lymphoma | Follicular Lymphoma Grade IIICzech Republic
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Stealth BioTherapeutics Inc.CompletedFuchs' Corneal Endothelial Dystrophy (FCED)United States
-
Hinova Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Highlight TherapeuticsPivotal S.L.Completed
-
HvivoPfizerRecruiting
-
Cara Therapeutics, Inc.CompletedPruritus | Uremic PruritusUnited States
-
Hoffmann-La RocheRecruitingAngelman SyndromeUnited States, Australia, Spain, Italy, France, Germany
-
Chinese PLA General HospitalUnknownAdvanced HER-2 Positive Solid Tumors | Chemotherapy Refactory | HER-2 Antibody Inhibitor Therapy RefactoryChina
-
Bial - Portela C S.A.Completed
-
Gustavo Reyes-TeranRecruiting
-
Cellid Co., Ltd.Active, not recruitingCOVID-19 | VaccinesKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation Trust; British Heart FoundationRecruitingCardiovascular Diseases | Dilated CardiomyopathyUnited Kingdom
-
MBX BiosciencesProSciento, Inc.RecruitingPostbariatric HypoglycemiaUnited States
-
Regeneron PharmaceuticalsRecruitingHealthy Volunteers | Non-alcoholic Fatty Liver Disease (NAFLD)United States